This study demonstrated that DNA vaccines could potentially be an effective alternative to anti-idiotypic antibody vaccination, although the mechanism by which such a therapy could target CSPG4-negative tumours requires further investigation. This evidence concerns the gene CSPG4 and neoplasm.